An observational study in Eosinopenia, sponsored by University Hospital, Strasbourg, France. Status unknown at 6 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-05-01.
Sponsored by University Hospital, Strasbourg, France · Observational
Several studies have described the interest of eosinopenia as a marker of infection in internal medicine or in intensive care units. Eosinopenia is an inexpensive and easily accessible biological marker of sepsis. Retrospective work in the adult emergency departments of Strasbourg University Hospitals has shown the good specificity of this biological sign for the diagnosis of infection. Our work aims to confirm the results by a more meaningful study.
Main objective: Evaluation of the interest of eosinopenia in the diagnosis of bacterial infection in ED.
Methodology: inclusion of all patients with criteria for bacterial infection in ED, inclusion of an equivalent number of uninfected control patients.
Duration : 12 months Multicentric prospective study 6 centers : Strasbourg, Hôpital Nord Franche comté, Sélestat, Wissembourg, Colmar, Mulhouse
Any adult emergency counseling subjects who benefit from the routine practice of NFS for any indication.
Exclusion Criteria:
Other: Diagnosis of bacterial infection
Other: Diagnosis of bacterial infection
use of eosinopenia in the diagnosis of bacterial infection
eosinopenia as a sepsis marker
Evaluation of the interest of eosinopenia in the diagnosis of infectious states in emergencies.
Time frame: 102 month
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France